Two days before the anniversary of Barry Sherman’s murder, Jonathon Sherman told his father’s longtime partner and friend Jack Kay to leave Apotex, the generic drug company the two men built over 35 years.Kay, the chief executive officer of Apotex, was sitting in his office last Tuesday when Jonathon Sherman walked in and said his services were no longer required, according to a source with knowledge of what happened. Kay was told to return to Apotex after business hours to collect his belongings.“It was like a gut punch. Actually, a gut punch is an understatement,” said an Apotex insider with knowledge of what happened on Dec. 11. By Monday of this week, Canada`s small pharmaceutical manufacturing industry was buzzing with the news that Kay was out the door. At the time of Kay’s dismissal, plans were being made for a company-wide day of mourning later that week. The bodies of Barry Sherman and his wife Honey were found in their Toronto home on Dec. 15, 2017, two days after they are believed to have been strangled there in what police have termed a “targeted” double homicide.For this story, the Star provided questions to Jonathon Sherman, and Apotex executives Jordan Berman and Jeff Watson. Read more:Apotex focused on navigating past ‘terrible tragedy’ after death of founder Barry ShermanWhere is Honey Sherman’s will?Sherman cousins lose appeal for piece of drug company’s billionsBerman responded with a statement confirming Kay’s departure, but did not answer questions about the manner of his departure or the apparent tensions between Kay and Barry Sherman’s son.“Upon the successful completion of our transition plan, Jack Kay is no longer with the company,” Berman wrote. “All of us at Apotex wish Jack the best of luck in his future pursuits. Jeff Watson, currently president and COO, is now ready to lead Apotex into the future. Jeff has been with Apotex for 24+ years, ...
|
